Mrs Cynthia K Lentsch, MS CCCSLP | |
1313 Big Horn Ave, Worland, WY 82401 | |
(307) 347-8677 | |
(307) 347-3242 |
Full Name | Mrs Cynthia K Lentsch |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 1313 Big Horn Ave, Worland, Wyoming |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134312283 | NPI | - | NPPES |
1770688871 | Medicaid | WY | |
09149025 | Other | NATL CERTIFICATION ASKA | |
SP320 | Other | WY | WY STATE BOARD OF SP & A |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | SP320 (Wyoming) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Cynthia K Lentsch, MS CCCSLP Po Box 1393, Worland, WY 82401 Ph: (307) 347-8677 | Mrs Cynthia K Lentsch, MS CCCSLP 1313 Big Horn Ave, Worland, WY 82401 Ph: (307) 347-8677 |
News Archive
Israeli and American researchers have identified new genetic data that could be used in the future to predict who will develop end-stage kidney disease (ESKD). ESKD requires dialysis or transplantation to sustain life, and is fatal in most regions of the world, where these treatments are not available.
Annually about 2000 Danish patients with colorectal cancer are treated with chemotherapy. Today, a range of different chemotherapeutic regimens are available. However, deciding which regimen to use is not easy.
Cubist Pharmaceuticals, Inc. today announced that it will oppose a motion filed by the Teva defendants to amend their answer to add a new defense in the patent litigation between Cubist and Teva pending in the US District Court for the District of Delaware. A motion for leave to amend the answer is a request to be permitted to add a new allegation. The Teva defendants seek leave to amend their answer to allege that US Patent Nos. 6,468,967 and 6,852,689 are unenforceable due to inequitable conduct.
Though it is well known obese individuals have a high incidence of persistent pain problems, a new study in The Journal of Pain, published by the American Pain Society, reports that comorbid obesity and pain also are linked to family history and mood disorders.
Agilent Technologies Inc. today announced that the U.S. Food and Drug Administration has approved its Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma.
› Verified 5 days ago
Mrs. Jennifer Lynn Ryan, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1313 Big Horn Ave, Worland, WY 82401 Phone: 307-347-8677 | |
Sally Nelson Hamer, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2909 Larkspur Ln, Worland, WY 82401 Phone: 307-202-2285 |